Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: (S)-tert-Butyl (1-(2-fluoro-6-nitro-N-phenylbenzamido)-1-oxobutan-2-yl)carbamate
CAS Number: 870281-84-8
Molecular Weight:  445.4465
Molecular Formula:  C22H24FN3O6
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.